Aesthetic medical products will be manufactured in Dmitrov for 285 million rubles.

Ekaterina Zinovieva, Deputy Prime Minister and Minister of Investment, Industry, and Science of the Moscow Region, announced that the plant's launch is scheduled for the third quarter of 2026. The facility will create over 80 jobs. The company plans to produce 521,600 units per year.

The investment project is being implemented on a one-hectare plot of land owned by the company. As Zinovieva noted, listing the project in the regional individual entrepreneurs' register will allow the company to reduce its profit tax rate from 25% to 10%, and the production will be completely exempt from property tax for the first four years after the facility's commissioning.

According to SPARK-Interfax, Gloreka-Pharma LLC was registered in January 2025 in the Moscow region. Its primary activity is the production of pharmaceuticals and materials used in medical and veterinary medicine. The company is 60% owned by KST LLC, and the remaining 40% by Toscani Laboratories LLC. Mikhail Selyanin holds shares in each company.

In late September 2025, the St. Petersburg company MedTechPlus announced the construction of a plant in the Dubna Special Economic Zone (SEZ) in the Moscow Region to manufacture medical devices for respiratory care and artificial ventilation, as well as medical consumables. The facility is scheduled to open in 2027. The investor estimates the investment at 300 million rubles. The production facility will cover 3,000 square meters.